These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 37881452)

  • 1. Typing myalgic encephalomyelitis by infection at onset: A DecodeME study.
    Bretherick AD; McGrath SJ; Devereux-Cooke A; Leary S; Northwood E; Redshaw A; Stacey P; Tripp C; Wilson J; Chowdhury S; Lewis I; Almelid Ø; Baby SV; Baker T; Becher H; Boutin T; Clyde M; Garcia D; Ireland J; Kerr SM; McDowall E; Perry D; Samms GL; Vitart V; Wolfe JC; Ponting CP
    NIHR Open Res; 2023; 3():20. PubMed ID: 37881452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DecodeME: community recruitment for a large genetics study of myalgic encephalomyelitis / chronic fatigue syndrome.
    Devereux-Cooke A; Leary S; McGrath SJ; Northwood E; Redshaw A; Shepherd C; Stacey P; Tripp C; Wilson J; Mar M; Boobyer D; Bromiley S; Chowdhury S; Dransfield C; Almas M; Almelid Ø; Buchanan D; Garcia D; Ireland J; Kerr SM; Lewis I; McDowall E; Migdal M; Murray P; Perry D; Ponting CP; Vitart V; Wolfe JC
    BMC Neurol; 2022 Jul; 22(1):269. PubMed ID: 35854226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer.
    Rowe PC; Underhill RA; Friedman KJ; Gurwitt A; Medow MS; Schwartz MS; Speight N; Stewart JM; Vallings R; Rowe KS
    Front Pediatr; 2017; 5():121. PubMed ID: 28674681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiopulmonary and metabolic responses during a 2-day CPET in myalgic encephalomyelitis/chronic fatigue syndrome: translating reduced oxygen consumption to impairment status to treatment considerations.
    Keller B; Receno CN; Franconi CJ; Harenberg S; Stevens J; Mao X; Stevens SR; Moore G; Levine S; Chia J; Shungu D; Hanson MR
    J Transl Med; 2024 Jul; 22(1):627. PubMed ID: 38965566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of Long COVID symptoms over one year.
    Oliveira CR; Jason LA; Unutmaz D; Bateman L; Vernon SD
    Front Med (Lausanne); 2022; 9():1065620. PubMed ID: 36698810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.
    Bested AC; Marshall LM
    Rev Environ Health; 2015; 30(4):223-49. PubMed ID: 26613325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-exertional malaise among people with long COVID compared to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Vernon SD; Hartle M; Sullivan K; Bell J; Abbaszadeh S; Unutmaz D; Bateman L
    Work; 2023; 74(4):1179-1186. PubMed ID: 36911963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year follow-up of young people with ME/CFS following infectious mononucleosis by Epstein-Barr virus.
    Pricoco R; Meidel P; Hofberger T; Zietemann H; Mueller Y; Wiehler K; Michel K; Paulick J; Leone A; Haegele M; Mayer-Huber S; Gerrer K; Mittelstrass K; Scheibenbogen C; Renz-Polster H; Mihatsch L; Behrends U
    Front Pediatr; 2023; 11():1266738. PubMed ID: 38304441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of and risk factors for severe cognitive and sleep symptoms in ME/CFS and MS.
    Jain V; Arunkumar A; Kingdon C; Lacerda E; Nacul L
    BMC Neurol; 2017 Jun; 17(1):117. PubMed ID: 28633629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The status of and future research into Myalgic Encephalomyelitis and Chronic Fatigue Syndrome: the need of accurate diagnosis, objective assessment, and acknowledging biological and clinical subgroups.
    Twisk FN
    Front Physiol; 2014; 5():109. PubMed ID: 24734022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A scoping review of 'Pacing' for management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): lessons learned for the long COVID pandemic.
    Sanal-Hayes NEM; Mclaughlin M; Hayes LD; Mair JL; Ormerod J; Carless D; Hilliard N; Meach R; Ingram J; Sculthorpe NF
    J Transl Med; 2023 Oct; 21(1):720. PubMed ID: 37838675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term symptom severity and clinical biomarkers in post-COVID-19/chronic fatigue syndrome: results from a prospective observational cohort.
    Legler F; Meyer-Arndt L; Mödl L; Kedor C; Freitag H; Stein E; Hoppmann U; Rust R; Wittke K; Siebert N; Behrens J; Thiel A; Konietschke F; Paul F; Scheibenbogen C; Bellmann-Strobl J
    EClinicalMedicine; 2023 Sep; 63():102146. PubMed ID: 37662515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological and clinical factors associated with post-exertional malaise severity in patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Ghali A; Richa P; Lacout C; Gury A; Beucher AB; Homedan C; Lavigne C; Urbanski G
    J Transl Med; 2020 Jun; 18(1):246. PubMed ID: 32571354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring Symptom Fluctuations and Triggers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Using Novel Patient-Centred N-of-1 Observational Designs: A Protocol for a Feasibility and Acceptability Study.
    McDonald S; Tan SX; Banu S; van Driel M; McGree JM; Mitchell G; Nikles J
    Patient; 2022 Mar; 15(2):197-206. PubMed ID: 34368926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-Exertional Malaise in Patients with ME and CFS with Comorbid Fibromyalgia.
    McManimen SL; Jason LA
    SRL Neurol Neurosurg; 2017; 3(1):22-27. PubMed ID: 28603794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of CD8 T-cell dysfunction associated with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long COVID and treatment with a nebulized antioxidant/anti-pathogen agent in a retrospective case series.
    Gil A; Hoag GE; Salerno JP; Hornig M; Klimas N; Selin LK
    Brain Behav Immun Health; 2024 Mar; 36():100720. PubMed ID: 38327880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors for Developing Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Following Infectious Mononucleosis.
    Jason LA; Cotler J; Islam MF; Furst J; Katz BZ
    J Rehabil Ther; 2022; 4(1):1-5. PubMed ID: 35350440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical Care Situation of People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Germany.
    Froehlich L; Hattesohl DBR; Jason LA; Scheibenbogen C; Behrends U; Thoma M
    Medicina (Kaunas); 2021 Jun; 57(7):. PubMed ID: 34201825
    [No Abstract]   [Full Text] [Related]  

  • 20. ME/CFS and Post-Exertional Malaise among Patients with Long COVID.
    Jason LA; Dorri JA
    Neurol Int; 2022 Dec; 15(1):1-11. PubMed ID: 36648965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.